Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 8/20 | 0.53 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.47 |
| ▸ | ALK | Q9UM73 | 4/20 | 0.46 |
| ▸ | INSR | P06213 | 2/20 | 0.46 |
| ▸ | NPM1 | P06748 | 2/20 | 0.46 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.45 |
| ▸ | TLR9 | Q9NR96 | 3/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.44 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.44 |
| ▸ | MAPK7 | Q13164 | 1/20 | 0.44 |
| ▸ | IGF1R | P08069 | 1/20 | 0.43 |
| ▸ | MAP3K12 | Q12852 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL519780 | 0.79 | ALK (0.79) | ALKINSRNPM1 | |
| SCHEMBL15444830 | 0.78 | EGFR (0.57) | EGFRALKINSRNPM1CAMK2D | |
| SCHEMBL30957984 | 0.78 | EGFR (0.63) | EGFRALKNPM1CAMK2DIGF1R | |
| SCHEMBL17197381 | 0.77 | QDPR (0.46) | EGFRALKINSRTLR9TLR8 | |
| SCHEMBL18778514 | 0.73 | EGFR (0.82) | EGFR | |
| SCHEMBL30957983 | 0.73 | TTK (0.61) | EGFRLRRK2ALKINSRNPM1 | |
| SCHEMBL520447 | 0.72 | ALK (0.77) | ALKINSRNPM1 | |
| SCHEMBL19910021 | 0.70 | MAP3K12 (0.63) | LRRK2TLR9TLR8TLR7MAP3K12 | |
| SCHEMBL31706475 | 0.70 | TLR9 (0.47) | EGFRLRRK2TLR9TLR8TLR7 | |
| SCHEMBL3720414 | 0.70 | INSR (0.67) | EGFRLRRK2ALKINSRMAPK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110799190-B | Heterocyclic compounds | 卡都瑞恩医药有限公司 | 2024-04-19 | — | — | CN | disclosed |